Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

The mutants resulted from the ongoing SARS-CoV-2 epidemic have showed resistance to antibody neutralization and vaccine-induced immune response. The present study isolated and identified two novel SARS-CoV-2 neutralizing antibodies (nAbs) from convalescent COVID-19 patients. These two nAbs (XG81 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jiajia, Ding, Chengchao, He, Jun, Zhang, Yuqing, Ni, Shuangshuang, Zhang, Xiangyu, Chen, Qingqing, Wang, Jing, Huang, Lina, He, Hongliang, Li, Wenting, Ma, Huan, Jin, Tengchuan, Zhang, Siping, Gao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442604/
https://www.ncbi.nlm.nih.gov/pubmed/34539645
http://dx.doi.org/10.3389/fimmu.2021.715464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442604/
https://www.ncbi.nlm.nih.gov/pubmed/34539645
http://dx.doi.org/10.3389/fimmu.2021.715464

Ejemplares similares